COVID-19 and the endothelium

被引:71
|
作者
Jung, F. [1 ]
Krueger-Genge, A. [2 ]
Franke, R. P. [3 ]
Hufert, F. [4 ,5 ]
Kuepper, J. -H. [1 ,5 ]
机构
[1] Brandenburg Univ Technol Cottbus Senftenberg, Mol Cell Biol, Inst Biotechnol, Cottbus, Germany
[2] Fraunhofer Inst Appl Polymer Res IAP, Div Life Sci & Bioproc, Dept Healthcare Biomat & Cosmeceut, Potsdam, Germany
[3] Univ Ulm, Dept Biomat, Ulm, Germany
[4] Brandenburg Med Sch Fontane, Inst Microbiol & Virol, Senftenberg, Germany
[5] Brandenburg Med Sch Fontane & Univ Potsdam, Joint Fac Brandenburg Univ Technol Cottbus Senfte, Fac Hlth Sci, Potsdam, Germany
关键词
COVID-19; endocytosis; endothelial cell dysfunction; endotheliitis; PULMONARY-EMBOLISM; ACE2; SARS-COV-2; RECEPTOR; CORONAVIRUS; EXPRESSION; CELLS;
D O I
10.3233/CH-209007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is growing evidence that COVID-19 not only affects the lungs but beyond that the endothelial system. Recent studies showed that this can lead to microcirculatory impairments and in consequence to functional disorders of all inner organs. The combination of endothelial dysfunction with a generalized inflammatory state and complement elements may together contribute to the overall pro-coagulative state described in COVID-19 patients leading to venular as well as to arteriolar occlusions.
引用
收藏
页码:7 / 11
页数:5
相关论文
共 50 条
  • [41] COVID-19 and the cardiovascular system: An update
    Salabei, Joshua K.
    Asnake, Zekarias T.
    Ismail, Zeeshan H.
    Charles, Kipson
    Stanger, Gregory-Thomas
    Abdullahi, Abdullahi H.
    Abraham, Andrew T.
    Okonoboh, Peters
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2022, 364 (02) : 139 - 147
  • [42] Endothelial Dysfunction in Covid-19 Infection
    Otifi, Hassan M.
    Adiga, Balkur K.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2022, 363 (04) : 281 - 287
  • [43] COVID-19 Biogenesis and Intracellular Transport
    Mironov, Alexander A.
    Savin, Maksim A.
    Beznoussenko, Galina V.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
  • [44] Effects of COVID-19 on Respiratory System
    Karahalil, Bensu
    Deniz, Muhammed Ercan
    Iyigundogdu, Irem
    Tumer, Miray
    GAZI MEDICAL JOURNAL, 2020, 31 (3A): : 528 - 531
  • [45] The Rationale for Potential Pharmacotherapy of COVID-19
    Saber-Ayad, Maha
    Saleh, Mohamed A.
    Abu-Gharbieh, Eman
    PHARMACEUTICALS, 2020, 13 (05)
  • [46] COVID-19, Virology and Geroscience: A Perspective
    Vellas, C.
    Delobel, P.
    Barreto, P. De Souto
    Izopet, J.
    JOURNAL OF NUTRITION HEALTH & AGING, 2020, 24 (07) : 685 - 691
  • [47] Obesity and COVID-19: What are the Consequences?
    Steenblock, Charlotte
    Hassanein, Mohamed
    Khan, Emran G.
    Yaman, Mohamad
    Kamel, Margrit
    Barbir, Mahmoud
    Lorke, Dietrich E.
    Everett, Dean
    Bejtullah, Saqipi
    Lohmann, Tobias
    Lindner, Uwe
    Tahirukaj, Ermal
    Jirjees, Feras Jassim
    Soliman, Sameh S. M.
    Quitter, Friederike
    Bornstein, Stefan R.
    HORMONE AND METABOLIC RESEARCH, 2022, 54 (08) : 496 - 502
  • [48] The ocular surface, coronaviruses and COVID-19
    Willcox, Mark D. P.
    Walsh, Karen
    Nichols, Jason J.
    Morgan, Philip B.
    Jones, Lyndon W.
    CLINICAL AND EXPERIMENTAL OPTOMETRY, 2020, 103 (04) : 418 - 424
  • [49] Potential Protective Factors for Allergic Rhinitis Patients Infected with COVID-19
    Dong, Jiaoyue
    Su, Dingyuan
    Zhao, Binbin
    Han, Jiayang
    Tu, Mengjie
    Zhang, Kaifeng
    Wang, Fengling
    An, Yang
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (07) : 6633 - 6645
  • [50] COVID-19 and Diabetes: will Novel Drugs for Diabetes Help in COVID-19?
    Al-kuraishy, Hayder Mutter
    Al-Gareeb, Ali Ismail
    Mostafa-Hedeab, Gomaa
    Dubey, Rupal
    Prabhakar, Pranav Kumar
    Batiha, Gaber El-Saber
    CURRENT MOLECULAR PHARMACOLOGY, 2023, 16 (04) : 494 - 506